Skip to main content
Clinical Trials/NCT04514471
NCT04514471
Completed
N/A

Feasibility of Conducting a Telehealth Study Assessing the Removal of Filter Ventilation on Smoking Behavior and Biomarkers

Masonic Cancer Center, University of Minnesota2 sites in 1 country64 target enrollmentMarch 18, 2024

Overview

Phase
N/A
Intervention
Unventilated filter cigarettes
Conditions
Tobacco Use
Sponsor
Masonic Cancer Center, University of Minnesota
Enrollment
64
Locations
2
Primary Endpoint
Feasibility of approach - Drop outs
Status
Completed
Last Updated
3 months ago

Overview

Brief Summary

This open label, between-subject, randomized multi-center pilot study will assess the feasibility of conducting a study remotely with telehealth visits to assess the effect of cigarettes with minimal filter ventilation vs. moderate filter ventilation on smoking behavior and biomarkers of tobacco toxicant exposure. Subjective measures, alveolar carbon monoxide, blood pressure and cigarettes per a day will be collected remotely. Biological samples will be collected at home and mailed to the study clinic.

Detailed Description

Smokers of cigarettes with about 16-30% ventilation in their conventional cigarettes who meet eligibility criteria will enter 3 weeks of monitoring of usual brand smoking. Subjects will then be randomly assigned for a period of 6 weeks to one of two conditions: 1) ventilated cigarettes; or 2) unventilated cigarettes. Subjects in each condition will be unblinded to simulate real world conditions. Subjects are provided with a debit card (ClinCard) that has been loaded with the appropriate amount of money to cover self-purchased usual brand cigarette in baseline and the assigned study cigarettes during intervention. Weekly telehealth visits will be conducted during baseline and the 6 weeks on study cigarettes to collect study measures, followed by a one month follow-up.

Registry
clinicaltrials.gov
Start Date
March 18, 2024
End Date
June 30, 2025
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 21 years of age or older
  • Regular cigarette smoker
  • Currently smoking an eligible brand
  • Generally good health
  • Access to smartphone or tablet and a device with a functioning camera for telehealth visits. Also must have internet access.

Exclusion Criteria

  • Unstable health
  • Uncontrolled high blood pressure
  • Pregnant or breast-feeding

Arms & Interventions

Unventilated Filter Cigarette

Conventional cigarette with approximately 6-7% (non-menthol) and 5-6% filter ventilation (menthol).

Intervention: Unventilated filter cigarettes

Ventilated Filter Cigarette

Conventional cigarette with approximately 22-26% (non-menthol) and 35-38% filter ventilation (menthol).

Intervention: Ventilated filter cigarettes

Outcomes

Primary Outcomes

Feasibility of approach - Drop outs

Time Frame: Baseline through Week 6

Percent of drop-outs in baseline and post-randomization.

Feasibility of approach - Missing Data

Time Frame: Baseline through Week 6

Extent (percent) of missing data

Feasibility of approach - Participant Satisfaction

Time Frame: Baseline through Week 6

Degree of difficulty collecting data through telehealth visits, mailing in biosamples and self-purchase of cigarettes (descriptive statistics (e.g., percent or mean responses)

Secondary Outcomes

  • Change in mean cigarettes per day (CPD)(effect size for each arm calculated as the baseline minus the 6 week value divided by the SD of this difference)
  • Change in Total Nicotine Equivalents (TNE)(effect size for each arm calculated as the baseline minus the 6 week value divided by the SD of this difference)
  • Change in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)(effect size for each arm calculated as the baseline minus the 6 week value divided by the SD of this difference)

Study Sites (2)

Loading locations...

Similar Trials